BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3293218)

  • 1. Chemotherapy of advanced gastric cancer: present status, future prospects.
    Macdonald JS; Gohmann JJ
    Semin Oncol; 1988 Jun; 15(3 Suppl 4):42-9. PubMed ID: 3293218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A current overview of chemotherapy in advanced gastric cancer].
    Ogawa M
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2161-8. PubMed ID: 2660747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antineoplastic chemotherapy in advanced gastric cancer].
    Tanneberger S
    Arch Geschwulstforsch; 1982; 52(5):385-95. PubMed ID: 6756336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of chemotherapy in the treatment of advanced gastric and pancreas cancer.
    Kelsen D
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):58-66. PubMed ID: 8091242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of advanced gastric cancer.
    Wils J
    Semin Oncol; 1996 Jun; 23(3):397-406. PubMed ID: 8658224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
    Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of stomach cancer].
    Gropp C; Havemann K
    Z Gastroenterol; 1982 Dec; 20(12):703-9. PubMed ID: 6819730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.
    Cascinu S; Galizia E; Labianca R; Ferraù F; Pucci F; Silva RR; Luppi G; Beretta GD; Berardi R; Scartozzi M
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):37-43. PubMed ID: 20821330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new chemotherapeutic regimen in the treatment of advanced gastric cancer.
    Kozaczka A; Machalski M
    Neoplasma; 1990; 37(1):77-84. PubMed ID: 2320183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma.
    Kim YH; Shin SW; Kim BS; Kim JH; Kim JG; Mok YJ; Kim CS; Rhyu HS; Hyun JH; Kim JS
    Cancer; 1999 Jan; 85(2):295-301. PubMed ID: 10023695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
    Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
    Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly infusional 5-fluorouracil plus/minus other drugs for the treatment of advanced gastric cancer.
    Wilke H; Korn M; Vanhöfer U; Fink U; Stahl M; Preusser P; Köhne C; Klassen U; Harstrick A; Schmoll HJ; Seeber S
    J Infus Chemother; 1996; 6(3):123-6. PubMed ID: 9229322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances in chemotherapy for advanced gastric cancer: from the standpoint of survival advantages].
    Ohtsu A; Yoshida S; Miyata Y; Shimada Y
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):444-50. PubMed ID: 7887636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of gastric cancer: a review.
    Kelsen D
    Isr J Med Sci; 1988; 24(9-10):557-61. PubMed ID: 3060446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric cancer: complete chemotherapy response in an elderly woman: current status of treatment.
    Hagin GD; Jain A
    Am J Gastroenterol; 1985 Nov; 80(11):835-7. PubMed ID: 3840327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of chemotherapy of advanced esophageal and gastric cancer].
    Ogawa M
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2097-103. PubMed ID: 7184390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.